静脈内注射液の世界市場レポート 2025年

静脈内注射液市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は8.0％で、205億1,000万米ドルに成長します。予測期間の成長は、人口増加と高齢化、外科手術の増加、感染症罹患率の上昇、遠隔医療と遠隔患者モニタリング、予防ヘルスケアの重視、世界の医療安全保障投資、患者中心のケア動向などに起因すると考えられます。予測期間における主な動向としては、非経口栄養剤の需要増加、プレミックス輸液の採用増加、在宅輸液療法の拡大、電解質バランス輸液の導入、新規薬剤添加剤や補助剤の導入、モニタリング用スマート輸液システムの統合などが挙げられます。

がんの有病率の上昇が、今後数年間の静脈内注射液市場の成長を牽引すると予測されます。がんは、制御不能な細胞増殖を特徴とし、近隣組織への浸潤や体内の他領域への転移が可能な様々な疾患を包含します。静脈内注射液は、化学療法薬の投与や治療中の患者の水分補給を維持するために、がん治療で頻繁に利用されています。例えば、2024年2月、スイスに本部を置く政府間機関である世界保健機関（WHO）は、2050年までに新たに発生するがん患者は3,500万人を超え、2022年に報告された推定2,000万人から77％増加すると予測しました。その結果、がん罹患率の増加が静脈内注射液市場の成長を後押ししています。

また、外科手術の増加も静脈内注射液市場の拡大に寄与すると見られています。切開や侵襲的なアプローチで様々な疾患や障害を治療する外科手術は、水分補給、電解質バランス、投薬管理、緊急介入など、必要不可欠なサポートを静脈内注射液に依存しています。一例として、2023年9月に国際美容整形外科学会が発表したデータによると、2022年に世界の整形外科医が実施した手術件数は約1,490万件、非手術件数は1,880万件であり、総手術件数は11.2％増加しています。したがって、手術件数の増加が静脈内注射液市場の成長を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界静脈内注射液 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の静脈内注射液市場：成長率分析
• 世界の静脈内注射液市場の実績：規模と成長, 2019-2024
• 世界の静脈内注射液市場の予測：規模と成長, 2024-2029, 2034F
• 世界静脈内注射液総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の静脈内注射液市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 完全静脈栄養
• 末梢静脈栄養
• 世界の静脈内注射液市場栄養素別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 炭水化物
• ビタミンとミネラル
• アミノ酸単回投与
• 非経口脂質乳剤
• その他の栄養素
• 世界の静脈内注射液市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 基本的な静脈内（IV）溶液
• 栄養点滴（IV）液
• 血液静脈内（IV）溶液
• 薬剤静脈内（IV）溶液
• 洗浄静脈内（IV）溶液
• 世界の静脈内注射液市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• 外来手術センター
• ホームケア設定
• 世界の静脈内注射液市場完全静脈栄養（TPN）の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 炭水化物ソリューション
• アミノ酸ソリューション
• 脂質ソリューション
• 電解質溶液
• マルチビタミンソリューション
• 世界の静脈内注射液市場、末梢静脈栄養（PPN）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 炭水化物ソリューション
• アミノ酸ソリューション
• 脂質ソリューション
• 電解質溶液

第7章 地域別・国別分析

• 世界の静脈内注射液市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の静脈内注射液市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 静脈内注射液市場：競合情勢
• 静脈内注射液市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • Fresenius SE & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Baxter International Inc.
• Otsuka Pharmaceutical Co. Ltd.
• CSL Limited
• B. Braun Melsungen AG
• Grifols S.A.
• Terumo Corporation
• Nipro Corporation
• Sichuan Kelun Pharmaceutical Co. Ltd.
• Cipla Limited
• Hikma Pharmaceuticals PLC
• ICU Medical Inc.
• Gland Pharma Limited
• Cisen Pharmaceutical Co. Ltd.
• Amsino International Inc.
• JW Life Science Co. Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 静脈内注射液市場2029：新たな機会を提供する国
• 静脈内注射液市場2029：新たな機会を提供するセグメント
• 静脈内注射液市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Intravenous solutions are sterile liquids administered directly into a patient's bloodstream, primarily for purposes of hydration, medication delivery, or nutrient supplementation. These solutions play a crucial role in intravenous therapy, serving to restore or maintain normal fluid volume and electrolyte balance in situations where oral administration is not feasible.

The main types of products within the category of intravenous solutions include total parenteral nutrition (TPN) and peripheral parenteral nutrition. Total parenteral nutrition is a method employed to provide essential nutrients and fluids directly into the bloodstream for individuals unable to eat or absorb nutrients through the digestive system. Various nutrients, including carbohydrates, vitamins and minerals, single-dose amino acids, parenteral lipid emulsion, among others, are utilized in applications such as basic intravenous (IV) solution, nutritional intravenous (IV) solution, blood intravenous (IV) solution, drug intravenous (IV) solution, and irrigation intravenous (IV) solution. End users of these intravenous solutions include hospitals, clinics, ambulatory surgery centers, and home care settings.

The intravenous solutions market research report is one of a series of new reports from The Business Research Company that provides intravenous solutions market statistics, including intravenous solutions industry global market size, regional shares, competitors with an intravenous solutions market share, detailed intravenous solutions market segments, market trends and opportunities, and any further data you may need to thrive in the intravenous solutions industry. This intravenous solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intravenous solutions market size has grown strongly in recent years. It will grow from $14 billion in 2024 to $15.05 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to rise in surgical procedures, growing prevalence of chronic diseases, expansion of home healthcare, stringent regulations ensuring product safety, increased focus on patient hydration, global emergency preparedness initiatives.

The intravenous solutions market size is expected to see strong growth in the next few years. It will grow to $20.51 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to population growth and aging, increasing surgical interventions, rising incidence of infectious diseases, telemedicine and remote patient monitoring, focus on preventive healthcare, global health security investments, patient-centric care trends. Major trends in the forecast period include increased demand for parenteral nutrition solutions, rise in adoption of pre-mixed iv solutions, expansion of home infusion therapies, introduction of electrolyte-balanced solutions, introduction of novel drug additives and adjuncts, integration of smart iv systems for monitoring.

The rising prevalence of cancer is projected to drive the growth of the intravenous solutions market in the coming years. Cancer encompasses a range of diseases characterized by uncontrolled cell proliferation, with the capability to invade nearby tissues and metastasize to other areas of the body. Intravenous solutions are frequently utilized in cancer treatment to administer chemotherapy medications and maintain patient hydration throughout therapy. For example, in February 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, forecasted that by 2050, there would be over 35 million new cancer cases, marking a 77% increase from the estimated 20 million cases reported in 2022. Consequently, the increasing incidence of cancer is propelling the growth of the intravenous solutions market.

The increasing number of surgical procedures is also expected to contribute to the expansion of the intravenous solutions market. Surgical procedures, employed to treat various diseases and disorders through incisions or invasive approaches, rely on intravenous solutions for essential support, including hydration, electrolyte balance, medication administration, and emergency interventions. As an illustration, data from the International Society of Aesthetic Plastic Surgery in September 2023 revealed that in 2022, plastic surgeons worldwide conducted approximately 14.9 million surgical and 18.8 million non-surgical procedures, indicating an 11.2% increase in total procedures. Therefore, the growing number of surgical procedures is driving the growth of the intravenous solutions market.

Key companies in the intravenous solutions market are strategically focusing on the development of innovative syringes, such as pre-filled and ready-to-administer syringes, to gain a competitive advantage. Pre-filled and ready-to-administer syringes come preloaded with medication, designed for immediate use without the need for manual filling or preparation. For instance, in August 2023, GENIXUS Corp., a US-based healthcare company, introduced KinetiX Rocuronium Bromide Injection in 5 mL and 10 mL ready-to-administer (RTA) syringes. These syringes are made of transparent, durable polymer material, eliminating risks associated with glass syringes. They are pre-filled and ready for administration, saving time and reducing medication errors. The product possesses features such as RFID-enabled technology with KitCheck, intuitive labeling, and a color-coded plunger rod for rapid identification.

In August 2022, CSL Limited, an Australia-based specialty biotechnology company, acquired Vifor Pharma AG for an undisclosed amount. This strategic acquisition enables CSL Limited to diversify its portfolio, expand its product offerings, increase revenue, and access new markets. Vifor Pharma AG, based in Switzerland, is a pharmaceutical manufacturing company providing intravenous (IV) solutions for the treatment of iron deficiency, nephrology, and rare diseases.

Major companies operating in the intravenous solutions market report are Pfizer Inc., Abbott Laboratories, Eli Lilly and Company, Fresenius SE & Co. KGaA, Becton, Dickinson and Company, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., CSL Limited, B. Braun Melsungen AG, Grifols S.A., Terumo Corporation, Nipro Corporation, Sichuan Kelun Pharmaceutical Co. Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, ICU Medical Inc., Gland Pharma Limited, Cisen Pharmaceutical Co. Ltd., Amsino International Inc., JW Life Science Co. Ltd., Eurolife Healthcare Pvt. Ltd., Huaren Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd., Claris Lifesciences Limited, Amanta Healthcare Ltd., Axa Parenterals Ltd., Wockhardt Ltd., Liqvor pharmaceuticals cjsc, Soxa Formulations & Research Pvt.Ltd., Aculife Healthcare Pvt. Ltd.

North America was the largest region in the intravenous solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the intravenous solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The intravenous solutions market consists of sales of dextrose 5% in water (D5W), 0.45% sodium chloride (half normal saline), dextrose 5% in normal saline (D5NS), 0.2% sodium chloride (hypotonic saline), and dextrose 10% in water (D10W). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intravenous Solutions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on intravenous solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for intravenous solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The intravenous solutions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Total Parenteral Nutrition; Peripheral Parenteral Nutrition
• 2) By Nutrients: Carbohydrates; Vitamins And Minerals; Single Dose Amino Acids; Parenteral Lipid Emulsion; Other Nutrients
• 3) By Application: Basic Intravenous (IV) Solution; Nutritional Intravenous (IV) Solution; Blood Intravenous (IV) Solution; Drug Intravenous (IV) Solution; Irrigation Intravenous (IV) Solution
• 4) By End User: Hospitals; Clinics; Ambulatory Surgery Centers; Home Care Settings
• Subsegments:
• 1) By Total Parenteral Nutrition (TPN): Carbohydrate Solutions; Amino Acid Solutions; Lipid Solutions; Electrolyte Solutions; Multivitamin Solutions
• 2) By Peripheral Parenteral Nutrition (PPN): Carbohydrate Solutions; Amino Acid Solutions; Lipid Solutions; Electrolyte Solutions
• Companies Mentioned: Pfizer Inc.; Abbott Laboratories; Eli Lilly and Company; Fresenius SE & Co. KGaA; Becton, Dickinson and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Intravenous Solutions Market Characteristics

3. Intravenous Solutions Market Trends And Strategies

4. Intravenous Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Intravenous Solutions Growth Analysis And Strategic Analysis Framework

• 5.1. Global Intravenous Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Intravenous Solutions Market Growth Rate Analysis
• 5.4. Global Intravenous Solutions Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Intravenous Solutions Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Intravenous Solutions Total Addressable Market (TAM)

6. Intravenous Solutions Market Segmentation

• 6.1. Global Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Total Parenteral Nutrition
• Peripheral Parenteral Nutrition
• 6.2. Global Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Carbohydrates
• Vitamins And Minerals
• Single Dose Amino Acids
• Parenteral Lipid Emulsion
• Other Nutrients
• 6.3. Global Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Basic Intravenous (IV) Solution
• Nutritional Intravenous (IV) Solution
• Blood Intravenous (IV) Solution
• Drug Intravenous (IV) Solution
• Irrigation Intravenous (IV) Solution
• 6.4. Global Intravenous Solutions Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Ambulatory Surgery Centers
• Home Care Settings
• 6.5. Global Intravenous Solutions Market, Sub-Segmentation Of Total Parenteral Nutrition (TPN), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Carbohydrate Solutions
• Amino Acid Solutions
• Lipid Solutions
• Electrolyte Solutions
• Multivitamin Solutions
• 6.6. Global Intravenous Solutions Market, Sub-Segmentation Of Peripheral Parenteral Nutrition (PPN), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Carbohydrate Solutions
• Amino Acid Solutions
• Lipid Solutions
• Electrolyte Solutions

7. Intravenous Solutions Market Regional And Country Analysis

• 7.1. Global Intravenous Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Intravenous Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Intravenous Solutions Market

• 8.1. Asia-Pacific Intravenous Solutions Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Intravenous Solutions Market

• 9.1. China Intravenous Solutions Market Overview
• 9.2. China Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Intravenous Solutions Market

• 10.1. India Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Intravenous Solutions Market

• 11.1. Japan Intravenous Solutions Market Overview
• 11.2. Japan Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Intravenous Solutions Market

• 12.1. Australia Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Intravenous Solutions Market

• 13.1. Indonesia Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Intravenous Solutions Market

• 14.1. South Korea Intravenous Solutions Market Overview
• 14.2. South Korea Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Intravenous Solutions Market

• 15.1. Western Europe Intravenous Solutions Market Overview
• 15.2. Western Europe Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Intravenous Solutions Market

• 16.1. UK Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Intravenous Solutions Market

• 17.1. Germany Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Intravenous Solutions Market

• 18.1. France Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Intravenous Solutions Market

• 19.1. Italy Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Intravenous Solutions Market

• 20.1. Spain Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Intravenous Solutions Market

• 21.1. Eastern Europe Intravenous Solutions Market Overview
• 21.2. Eastern Europe Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Intravenous Solutions Market

• 22.1. Russia Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Intravenous Solutions Market

• 23.1. North America Intravenous Solutions Market Overview
• 23.2. North America Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Intravenous Solutions Market

• 24.1. USA Intravenous Solutions Market Overview
• 24.2. USA Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Intravenous Solutions Market

• 25.1. Canada Intravenous Solutions Market Overview
• 25.2. Canada Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Intravenous Solutions Market

• 26.1. South America Intravenous Solutions Market Overview
• 26.2. South America Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Intravenous Solutions Market

• 27.1. Brazil Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Intravenous Solutions Market

• 28.1. Middle East Intravenous Solutions Market Overview
• 28.2. Middle East Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Intravenous Solutions Market

• 29.1. Africa Intravenous Solutions Market Overview
• 29.2. Africa Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Intravenous Solutions Market Competitive Landscape And Company Profiles

• 30.1. Intravenous Solutions Market Competitive Landscape
• 30.2. Intravenous Solutions Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Fresenius SE & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Intravenous Solutions Market Other Major And Innovative Companies

• 31.1. Baxter International Inc.
• 31.2. Otsuka Pharmaceutical Co. Ltd.
• 31.3. CSL Limited
• 31.4. B. Braun Melsungen AG
• 31.5. Grifols S.A.
• 31.6. Terumo Corporation
• 31.7. Nipro Corporation
• 31.8. Sichuan Kelun Pharmaceutical Co. Ltd.
• 31.9. Cipla Limited
• 31.10. Hikma Pharmaceuticals PLC
• 31.11. ICU Medical Inc.
• 31.12. Gland Pharma Limited
• 31.13. Cisen Pharmaceutical Co. Ltd.
• 31.14. Amsino International Inc.
• 31.15. JW Life Science Co. Ltd.

32. Global Intravenous Solutions Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Intravenous Solutions Market

34. Recent Developments In The Intravenous Solutions Market

35. Intravenous Solutions Market High Potential Countries, Segments and Strategies

• 35.1 Intravenous Solutions Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Intravenous Solutions Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Intravenous Solutions Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer